These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22355905)

  • 81. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
    Liu G; Black KL; Yu JS
    Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glioma-specific antigens for immune tumor therapy.
    Skog J
    Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Antibody-based therapy for brain tumor].
    Takasu S; Yoshikawa K; Yoshida J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():563-8. PubMed ID: 16201582
    [No Abstract]   [Full Text] [Related]  

  • 84. [Immunotherapy for brain tumor: don't get "Lost in Translation"].
    Okada H
    No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763
    [No Abstract]   [Full Text] [Related]  

  • 85. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Emerging targeted treatments for malignant glioma.
    Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
    Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
    Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Chemotherapy of brain tumor (author's transl)].
    Hoshino T
    No To Shinkei; 1976 Aug; 28(8):739-50. PubMed ID: 799933
    [No Abstract]   [Full Text] [Related]  

  • 89. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
    Hodge JW; Ardiani A; Farsaci B; Kwilas AR; Gameiro SR
    Semin Oncol; 2012 Jun; 39(3):323-39. PubMed ID: 22595055
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumor fighter.
    Kiser K
    Minn Med; 2012 Jan; 95(1):16-9. PubMed ID: 22355905
    [No Abstract]   [Full Text] [Related]  

  • 91. Vaccines for glioblastoma and high-grade glioma.
    Wheeler CJ; Black KL
    Expert Rev Vaccines; 2011 Jun; 10(6):875-86. PubMed ID: 21692706
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Therapeutic analysis of in vitro and in vivo brain tumor models.
    Schuster JM; Friedman HS; Bigner DD
    Neurol Clin; 1991 May; 9(2):375-82. PubMed ID: 1944106
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.